4.4 Article

Protective effect of teprenone on gastric mucosal injury induced by dual antiplatelet therapy in rats

期刊

AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
卷 13, 期 4, 页码 2702-2709

出版社

E-CENTURY PUBLISHING CORP

关键词

Teprenone; aspirin; clopidogrel; rats; gastric mucosal injury

资金

  1. Science and Technology Program of Quanzhou [2018Z045]

向作者/读者索取更多资源

Teprenone protects against gastric mucosal injury induced by dual antiplatelet therapy through inhibiting gastric mucosal inflammation, inhibiting oxidative stress, and improving gastric mucosa indices.
Objective: To investigate the protective effect of teprenone on gastric mucosal injury induced by dual antiplatelet therapy in rats. Methods: Healthy, specifically pathogen free SD, rats were selected and divided into 4 groups: Normal group (normal rats, without any treatment), Model group (rats received dual antiplatelet therapy: aspirin and clopidogrel), Teprenone group (rats received dual antiplatelet therapy and teprenone) and Pantoprazole group (rats received dual antiplatelet therapy and pantoprazole). The gastric mucosal blood flow, ulcer index, gastric gel mucus thickness, the levels of gastrin (Gas), prostaglandin (PG), prostaglandin E-2 (PGE(2)), endothelin-1 (ET-1) tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6 and IL-10 in serum, the levels of malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD) and myeloperoxidase (MPO) in the gastric mucosa, as well as the expression of vascular endothelial growth factor (VEGF) in the rat's stomach were measured. Results: Compared with the Normal group, the other groups showed more severe gastric injury, elevated levels of inflammatory factors (TNF-alpha, IL-1 beta, IL-6 and IL-10), elevated levels of MDA and MPO, as well as reduced levels of GSH, SOD and VEGF (all P<0.05). Compared with the Model group, the gastric mucosal lesions in the Teprenone group and the Pantoprazole group were improved significantly (both P<0.05). Compared with the Pantoprazole group, the Teprenone group had reduced levels of ET-1 and elevated levels of PG and PGE(2) (all P<0.05). Conclusion: Teprenone protects against gastric mucosal injury induced by dual antiplatelet therapy through inhibiting gastric mucosal inflammation inhibiting oxidative stress and improving gastric mucosa indices.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据